Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Patients with MS have more heart problems

Patients with multiple sclerosis (MS) may have more cardiovascular dysfunction, including impaired biventricular function and reduced left atrial function, according to a new study published in Scientific Reports.

Startup combines food, tech for diabetes prevention

San Francisco-based startup PlateJoy, a personalized meal-planning company, will add weight tracking and virtual coaching to its services to treat individuals with prediabetes.

Hydrogel efficient in reducing unfavorable outcomes in patients with intracranial aneurysms

Endovascular coil embolization with second-generation hydrogel coils could decrease the rate of unfavorable outcomes in patients with small- and medium-sized intracranial aneurysms, according to a new study published in Stroke.

Thumbnail

ACC honors transplant recipient as part of CardioSmart program

The American College of Cardiology has recognized Melissa Cappuccilli, a nurse and single mother of four who received a heart transplant in 2013, as a part of its “I am CardioSmart” contest.

Thumbnail

Eating yogurt may decrease the risk of CVD

At least two servings of yogurt per week can decrease the chances of developing cardiovascular disease (CVD) by up to 30 percent in hypertensive adults, according to a new study published in the American Journal of Hypertension.

CABG tops PCI for those with diabetes, heart disease and left ventricular dysfunction

Coronary artery bypass grafting (CABG) is preferred to percutaneous coronary intervention for patients with diabetes and coronary artery disease (CAD). But new research showed CABG outperformed PCI when focusing specifically on individuals with left ventricular dysfunction (LVD), a population that had been excluded in past studies.

What to expect at ACC 2018

The name of the game at this year’s American College of Cardiology (ACC) Scientific Sessions is innovation. Between thousands of handpicked poster sessions, 20 late-breakers and a handful of featured clinical research trials, presenters will focus on the latest in cutting-edge cardiology, ACC leaders said at a Wednesday, Feb. 21 briefing.

Thumbnail

Corindus’ CorPath GRX cleared for both PCI, peripheral vascular intervention

Already approved for robot-assisted PCI, Corindus Vascular Robotics’ CorPath GRX System is now cleared by the FDA for peripheral vascular interventions (PVIs). The system is the first to receive FDA clearance for both procedures.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.